Companies

PDS Biotechnology Corp (PDSB) SEC filings

CIK 0001472091 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-40.9 M-16.9 M
Diluted EPS (USD/shares)-0.74-1.39-1.43

Latest filings

FiledFormDescriptionPeriod
2026-10-214FORM 42026-10-18
2026-10-213FORM 32026-10-18
2026-10-218-K8-K items 8.01,9.012026-10-20
2026-10-204FORM 42026-10-18
2026-10-204FORM 42026-10-18
2026-10-203FORM 32026-10-18
2026-10-203FORM 32026-10-18
2026-10-208-K8-K items 5.02,8.01,9.012026-10-18
2026-10-14S-3S-3
2026-10-068-K8-K items 8.01,9.012026-10-06
2026-09-228-K8-K items 8.01,9.012026-09-22
2026-09-21SCHEDULE 13DSCHEDULE 13D
2026-09-21332026-09-14
2026-09-21332026-09-14
2026-09-218-K8-K items 8.01,9.012026-09-21
2026-09-183FORM 32026-09-12
2026-09-148-K8-K items 1.02,5.02,7.01,8.01,9.012026-09-12
2026-09-088-K8-K items 1.01,3.02,7.01,9.012026-09-07
2026-09-048-K8-K items 1.01,2.03,9.012026-08-31
2026-08-258-K8-K items 2.05,5.022026-08-21
2026-08-198-K8-K items 5.022026-08-13
2026-08-148-K8-K items 5.03,5.07,9.012026-08-10
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-08-118-K8-K items 7.01,9.012026-08-11

Forms on file (last 1,000): 8-K 280, 4 222, 3 45, 10-Q 33, CORRESP 23, S-8 17, SC 13G/A 13, DEFA14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PDSB (0.002 USD), /gw/filings/filings?ticker=PDSB&form=8-K, /gw/filings/facts?ticker=PDSB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange